Thynk Capital

United States; North America
Is it you?
Investor info
Type
Venture Capital
Stage focus
  • Seed Round,
  • Early stage VC,
  • Later stage VC,
  • Recapitalization,
  • Other
Current fund size
$ 10,000,000
Industry focus
Description
Thynk Capital is a venture capital investment firm that invests in therapeutics, healthcare and technology companies. The firm focuses on early stage pharma and biotech developing treatment to Extend Healthy lifespan and address the major diseases of Aging including Alzheimer's, Dementia, Kidney Disease, Cancer, Diabetes, Frailty and Rare Disease.
Relevant investments
  • Company
    Amount
    Round
  • Example example company Inc
    $ 1,000,000
    Investor meetings
  • Company & Company
    € 11,000,000
    Series C funding
  • Example
    $ 524,000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Healthcare IT
Made with in San Francisco, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.